Kharkiv Regional Clinical Oncology Center

Kharkiv 61070

0 studies enrolling now · 4 studies all time

What they study most

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, DLBCL Transformed From Indolent Lymphoma, Diffuse Large B-cell Lymphoma, Follicular Grade 3 Lymphoma, Recurrent or Persistent Endometrial Carcinoma, UC (Urothelial Cancer), de Novo DLBCL

Studies at this site

• Pembrolizumab in Combination With Epacadostat or Placebo in Cisplatin-ineligible Urothelial Carcinoma (KEYNOTE-672/ECHO-307) — Completed
• Comparison of Pixantrone + Rituximab With Gemcitabine + Rituximab in Patients With Aggressive B-cell Non-Hodgkin Lymphoma or Follicular Grade 3 Lymphoma Who Have Relapsed After Therapy and Are Not Eligible for Stem Cell Transplant — Completed
• BIBW 2992 (Afatinib) Versus Chemotherapy as First Line Treatment in NSCLC With EGFR Mutation — Completed
• Virexxa (Sodium Cridanimod) w/Progestin Therapy in Pts w/Progesterone Receptor Neg Recurrent/Persistent Endometrial CA — Status unconfirmed